AMP Optimistic in Suit to invalidate Patents on Breast Cancer Genes

Now that the Supreme Court has remanded Association for Molecular Pathology et al. v. Myriad Genetics, Inc., et al. (AMP v. Myriad) to the Court of Appeals for the Federal Circuit for further consideration, AMP is optimistic that it will ultimately prevail in its lawsuit to invalidate patents on two genes that are known to cause breast cancer.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews